Completed

Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland [Prospektive Systemanalyse Der Saisonalen Influenza - Virustransmission Und Evolution in Der Stadt Basel] in German

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
DNA Samples
Who is being recruted

Infections+4

+ Influenza, Human

+ Orthomyxoviridae Infections

+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Ecologic or Community

Assessing exposures and health outcomes at the community level in order to identify population-wide health trends.
Observational
Study Start: January 2017
See protocol details

Summary

Principal SponsorUniversity Hospital, Basel, Switzerland
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2017

Actual date on which the first participant was enrolled.

In this prospective observational study, paediatric and adult outpatients presenting with influenza-like illness will be enrolled at the emergency departments of the University Hospital Basel (USB), the paediatric University Hospital of both Basel (UKBB), or a network of family doctors (associated with Center of Primary Health Care). The Clinical Trial Unit at the University Hospital Basel will coordinated the recruitment process, collect data and sample all patients during the influenza season 2016/17. Samples will be collected such as whole blood, serum and DNA, nasopharyngeal swamps to diagnose influenza by polymerase chain reaction (PCR) assay and to determine colonization rates with Staphylococcus aureus and Streptococcus pneumonia. All samples except the first naso-pharyngeal swab for influenza diagnostics will be stored in a biobank and analysed in batches. Each influenza virus isolate will be sequenced using a "whole genome sequencing" approach. The viral transmission and evolution will be analysed using whole genome data for a detailed molecular and phylogenetic tree analysis, respectively. The epidemiological and geographical data will be incorporated into the phylogenetic model. Specific aims are: (i) to determine the impact of the most important epidemiological parameters, first focusing on the age profile, followed by children per house hold, and population density, on influenza transmission at an individual and population level, drawing on an analysis of baseline humoral immunity and whole genome sequencing data, (ii) to understand the viral evolution during seasonal epidemics, (iii) to develop dynamic mathematical models that are able to predict viral transmission and evolution based on the retrospective results from (i) and (ii) and to validate this model in future influenza seasons. To realize the interdisciplinary approach, the investigators will rely on the expertise in mathematical modelling of viral epidemiology and evolution and established geographical expertise, next generation sequencing, clinical epidemiology, and immunologic diagnostic techniques.

Official TitleProspective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland [Prospektive Systemanalyse Der Saisonalen Influenza - Virustransmission Und Evolution in Der Stadt Basel] in German
NCT03010007
Principal SponsorUniversity Hospital, Basel, Switzerland
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

800 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Ecologic or Community

These studies look at groups or populations rather than individuals. They explore community-wide exposures and health outcomes to understand public health trends and risks at a broader scale.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

InfectionsInfluenza, HumanOrthomyxoviridae InfectionsRespiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus InfectionsVirus Diseases

Criteria

4 inclusion criteria required to participate
Each pediatric or adult patient, which fulfill the Worl Health Organization (WHO) definition of Influenza like illness.

The case definition includes an acute respiratory infection with coughing, fever ≥38°C, and start of symptoms within the last 10 days.

Presentation of the patient with influenza-like illness on the emergency ward of the University Hospital Basel or the University Children Hospital of both Basel or a collaborating private practise.

Patient has to live in the city of Basel.

2 exclusion criteria prevent from participating
Patients who are not living in the City of Basel.

Case definition for influenza like illness is not fulfilled.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 4 locations

Suspended

Federal Institute of Technology Zurich

Basel, SwitzerlandOpen Federal Institute of Technology Zurich in Google Maps
Suspended

University Children's Hospital

Basel, Switzerland
Suspended

University Hospital Basel

Basel, Switzerland
Suspended

Universitätres Zentrum für Hausarztmedizin beider Basel, University of Basel

Basel, Switzerland
Completed4 Study Centers